Journal of Targeted Oncology Research

Frequency : Quarterly
Editorial & Review Timeline
3 - 9 Days Initial Quality Review
14 Days Peer Evaluation Summary
80% Final Acceptance Rate After Peer Review
35 - 45 Days Complete Editorial Processing Time

Immuno-Oncology

Immuno-Oncology focuses on therapies like immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, which enhance immune responses against tumors. This approach offers durable, personalized treatment, transforming cancer care by improving survival and reducing relapse rates